Resmed INC RESMED ORD SHS
Resmed INC RESMED ORD SHS/ US7611521078 /
0KW4
|
2024-03-20 12:00:00 AM
|
Chg.
-
|
Volume |
Bid6:00:08 AM |
Ask6:00:08 AM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
192.22USD
|
-
|
44
Turnover: - |
-Bid Size: - |
-Ask Size: - |
31.17 bill.USD |
0.83% |
34.67 |
Fundamentals
| |
FY 2023 |
Growth (1Y) |
| Per Share |
|
| Earnings per Share: |
6.12 USD |
14.61% |
| EPS Diluted: |
6.09 USD |
14.91% |
| Revenues per Share: |
28.71 USD |
17.50% |
| Book Value per Share: |
28.08 USD |
22.35% |
| Cash Flow per Share: |
4.71 USD |
96.57% |
| Dividend per Share: |
1.76 USD |
4.76% |
| Total |
in mill. |
|
| Revenues: |
4,222.99 USD |
18.02% |
| Net Income: |
897.56 USD |
15.15% |
| Operating Cash Flow: |
693.30 USD |
- |
| Cash and Cash Equivalents: |
227.89 USD |
- |
Valuation Ratios
| |
Current |
Latest FY* |
| P/E Ratio: |
34.67 |
35.70 |
| P/S Ratio: |
7.39 |
7.61 |
| P/BV ratio: |
7.56 |
7.78 |
| P/CF Ratio: |
45.01 |
46.35 |
| PEG: |
2.37 |
2.44 |
| Earnings Yield: |
2.88% |
2.80% |
| Dividend Yield: |
0.83% |
0.81% |
| Market Capitalization |
|
| Market Capitalization: |
31.17 bill. USD |
32.14 bill. USD |
| Free Float Market Cap.: |
- USD |
- USD |
| Market Cap. / Employee: |
- USD |
- USD |
| Shares Outstanding: |
146.91 mill. |
|
Profitability
| Gross Profit Margin: |
55.78% |
| EBIT Margin: |
26.80% |
| Net Profit Margin: |
21.25% |
| Return on Equity: |
21.73% |
| Return on Assets: |
13.29% |
Financial Strength
| Liquidity I / Cash Ratio: |
30.04% |
| Liquidity II / Quick Ratio: |
122.97% |
| Liquidity III / Current Ratio: |
312.16% |
| Debt / Equity Ratio: |
63.48% |
| Dynam. Debt / Equity Ratio: |
378.16% |
Efficiency
| Employees: |
- |
| Personal Expenses / Employee: |
- USD |
| Revenues / Employee: |
- USD |
| Net Income / Employee: |
- USD |
| Total Assets / Employee: |
- USD |
| * Fiscal Year End: |
2023-06-30 |
| Accounting Standard: |
US GAAP |
